Clinical Trial Update: A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the combination of anti-PD1 antibody-activated tumor-infiltrating lymphocytes (TILs) with chemotherapy in colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• anti-PD1 antibody-activated TILs (PD-1 antibody-activated tumor-infiltrating lymphocytes)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Stage III | Phase 1, Phase 2 | Status: UNKNOWN